HPS Pharmacies wish to give notice of ongoing interruptions to the supply of:
ADT® Booster Vaccine
|Medicine||Diphtheria toxoid 2 international units/0.5 mL, and
Tetanus toxoid 20 international units/0.5 mL
|Presentation||0.5mL pre-filled syringe|
|Sponsor||bioCSL (Australia) Pty Ltd|
|Aust R.||130906 and 130919|
The interruptions to supply of ADT® Booster Vaccine are due to repeated delays in the release of shipments from the manufacturer which are expected to continue until early March 2015. During this time, bioCSL are carefully managing the release of available supplies to meet the most urgent needs of patients.
While no other directly equivalent product is available in Australia, other vaccines combine acellular pertussis +/- polio antigens with diphtheria toxoid and tetanus toxoid in the reduced doses which suit adults, adolescents and children aged ≥10 years, although these products are not included in the Pharmaceutical Benefits Scheme.
The Immunisation Handbook identifies the following similar products:
- Diphtheria, tetanus, acellular pertussis: Adacel® / Boostrix®
- Diphtheria, tetanus, acellular pertussis, inactivated poliovirus: Adacel Polio® / Boostrix-IPV®
Please retain this notice in a prominent position, including in other related business units as a reminder for all staff members until supply returns to normal.
Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies, or CSL Customer Service on 1800 008 275.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.